COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,955 Articles (22,604 medRxiv, 8,351 bioRxiv)

Most recent first Previous |  Page 347: Articles 3461-3470  | Next

SARS-CoV-2 in 30 Months, Indonesia Data Tells: Study from a Reference Laboratory in North Jakarta and Its Reflection for Regional to National COVID-19 Situation
Kaisar, M. M. M., Widowati, T. A., Kristin, H., Jonnatan, S., Surja, S. S., Tjoa, E., Wijaya, J. W., Venna, V., Ali, S.
10.1101/2023.07.27.23293237 — Posted: 2023-07-31
An updated research focus on the employment of computer-aided drug discovery and repurposing techniques for the identification and evaluation of SARS-CoV-2 Main protease inhibitors: A protocol for a systematic review and meta-analysis
MUSHEBENGE, A. G.-A., Ugbaja, S. C., Mbatha, N. A., Riziki, M. G., Muzumbukilwa, T. W., Kadima, M. G., Nlooto, M. Z., Kumalo, H. M.
10.1101/2023.07.28.23293282 — Posted: 2023-07-31
QJHong Model for Novel Coronavirus Disease 2019 (COVID-19) in the United States
Mehta, A., Hong, Q.-J.
10.1101/2023.07.30.23293233 — Posted: 2023-07-31
Immunities Specific to Both of the M Protein Ectodomain and RBD Synergize to Confer Cross-protection against SARS-CoV-2 Infections
Tang, Y., Tang, K., Hu, Y., Ye, Z.-W., Luo, W., Luo, C., Cao, H., Wang, R., Liu, D., Liu, C., Ge, X., Chen, Y., Yuan, S., Deng, L.
10.1101/2023.07.31.551223 — Posted: 2023-07-31
Prolonged exposure to lung-derived cytokines is associated with inflammatory activation of microglia in patients with COVID-19
Grant, R. A., Poor, T. A., Sichizya, L., Diaz, E., Bailey, J. I., Soni, S., Senkow, K. J., Perez-Leonor, X. G., Abdala-Valencia, H., Lu, Z., Donnelly, H. K., Tighe, R. M., Lomasney, J. W., Wunderink, R. G., Singer, B. D., Misharin, A. V., Budinger, G. R. S., The NU SCRIPT Investigators
10.1101/2023.07.28.550765 — Posted: 2023-07-28
The Impact of Post Embryo Transfer SARS-CoV-2 Infection on Pregnancy in In Vitro Fertilization: A Prospective Cohort Study
Ding, Y.-B., Li, X.-F., Zhang, Y.-J., Wan, Q., Yao, Y.-L., Chen, M.-X., Wang, M.-D., Wang, L.-L., Hu, X.-Y., Tang, X.-J., Zhong, Z.-H., Fu, L.-J., Luo, X., Lv, X.-Y., Geng, L.-H.
10.1101/2023.07.25.23293116 — Posted: 2023-07-28
Trends and factors associated with neonatal mortality among Neonates hospitalized at the Women and Newborn Hospital in Lusaka Zambia in the pre-covid 19 period
Tembo, D., Kaonga, P., Mweene, C., Jacobs, C.
10.1101/2023.07.26.23293218 — Posted: 2023-07-28
Impact of Community Masking on SARS-CoV-2 Transmission in Ontario after Adjustment for Differential Testing by Age and Sex
Peng, A., Bosco, S., Tuite, A., Simmons, A., Fisman, D.
10.1101/2023.07.26.23293155 — Posted: 2023-07-28
Phenotypic grouping of Catheter-Associated Escherichia coli from COVID-19 isolation wards using Hierarchical clustering in Surabaya
Edbert, D., Endraswari, P. D., Mertaniasih, N. M.
10.1101/2023.07.26.23293190 — Posted: 2023-07-28
New design strategies for ultra-specific CRISPR-Cas13a-based RNA-diagnostic tools with single-nucleotide mismatch sensitivity
Molina Vargas, A. M., Osborn, R. M., Sinha, S., Arantes, P. R., Patel, A., Dewhurst, S., Palermo, G., O'Connell, M. R.
10.1101/2023.07.26.550755 — Posted: 2023-07-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).